Results 161 to 170 of about 10,004,929 (375)
Advances in the applications of monoclonal antibodies in clinical oncology. London, 28-30 May 1986 [PDF]
Mike Clark+20 more
openalex +1 more source
Landscape of BRAF transcript variants in human cancer
We investigate the annotation of BRAF variants, focusing on protein‐coding BRAF‐220 (formerly BRAF‐reference) and BRAF‐204 (BRAF‐X1). The IsoWorm pipeline allows us to quantify these variants in human cancer, starting from RNA‐sequencing data. BRAF‐204 is more abundant than BRAF‐220 and impacts patient survival.
Maurizio S. Podda+5 more
wiley +1 more source
Review of the “Oncology 2.0” Textbook under the Editorship of Professor Sh.Kh. Gantsev
The textbook “Oncology 2.0” by K.Sh. Gantsev, Sh.R. Kzyrgalia, F.V. Moiseenko, and R.S. Yamidanov, under the editorship of Professor Sh.Kh. Gantsev follows the history of the authors’ publications for more than 20 years, revealing the mechanisms of the ...
I. R. Rakhmatullina
doaj
Loss of proton‐sensing GPR4 reduces tumor progression in mouse models of colon cancer
G protein‐coupled receptor 4 (GPR4) is a pH‐sensing receptor activated by acidic pH. GPR4 expression is increased in patients with inflammatory bowel disease who are at high risk of developing colorectal cancer. In mouse models, loss of GPR4 attenuated tumor progression. This correlated with increased IL2 and natural killer cell activity.
Leonie Perren+16 more
wiley +1 more source
Focal Spot, Fall/Winter 1986 [PDF]
https://digitalcommons.wustl.edu/focal_spot_archives/1044/thumbnail ...
core +1 more source
Medical Oncology: Basic Principles and Clinical Management of Cancer. [PDF]
Paul Calabresi, Philip S. Schein
openalex +1 more source
TRPM8 levels determine tumor vulnerability to channel agonists
TRPM8 is a Ca2+ permissive channel. Regardless of the amount of its transcript, high levels of TRPM8 protein mark different tumors, including prostate, breast, colorectal, and lung carcinomas. Targeting TRPM8 with channel agonists stimulates inward calcium currents followed by emptying of cytosolic Ca2+ stores in cancer cells.
Alessandro Alaimo+18 more
wiley +1 more source
Understanding facilitators and barriers to contraception screening and referral in young women with cancer [PDF]
BACKGROUND: Young women with cancer often worry about impaired fertility after treatment but can experience devastating consequences from an unplanned pregnancy during treatment. Contraception screening and referral appear to occur infrequently in cancer
Lindsay, Sarah
core
Introduction Vulvar cancer may cause serious local symptoms that may impact negatively on the woman's health‐related quality of life (HRQOL). However, knowledge about the prevalence of vulvar and lymphedema symptoms at diagnosis and during follow‐up is ...
Diana Zach+8 more
doaj +1 more source